Squarepoint’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Squarepoint’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,498	Closed	-$21K	–	2886
2019 Q3	$21K	Buy	+1,498	New	+$22K	﹤0.01%	2272
2018 Q4	–	Sell	-3,024	Closed	-$65K	–	2301
2018 Q3	$65K	Sell	3,024 -1,867	-38%	-$56.8K	﹤0.01%	1912
2018 Q2	$210K	Buy	4,891 +2,158	+79%	+$98.8K	﹤0.01%	1522
2018 Q1	$178K	Sell	2,733 -924	-25%	-$65.5K	﹤0.01%	1514
2017 Q4	$267K	Buy	+3,657	New	+$302K	﹤0.01%	1599
2017 Q1	–	Sell	-2,591	Closed	-$240K	–	1971
2016 Q4	$240K	Buy	+2,591	New	+$292K	0.01%	1296
2016 Q3	–	Sell	-5,133	Closed	-$520K	–	1310
2016 Q2	$520K	Buy	+5,133	New	+$636K	0.03%	549
2016 Q1	–	Sell	-1,433	Closed	-$470K	–	1494
2015 Q4	$470K	Buy	+1,433	New	+$466K	0.05%	569
2015 Q2	–	Sell	-686	Closed	-$338K	–	637
2015 Q1	$338K	Buy	+686	New	+$266K	0.12%	267

Other funds holding LUMO

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Squarepoint's LUMO Position: Q4 2019 in Review

Squarepoint sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 1,498 shares — an estimated $21K sold.

Squarepoint first reported a position in LUMO in Q1 2015 and held it in 9 quarters. The position peaked at $520K in Q2 2016. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

Squarepoint reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Squarepoint sold 1,498 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $21K.
Squarepoint first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Squarepoint's Lumos Pharma, Inc. Common Stock position peaked at $520K in Q2 2016.
64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Squarepoint's 13F filing for Q4 2019, filed 14 Feb 2020.